Issn Print: 0923-7534
Publication Date: 2018/03/01
Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study
S M Swain; M S Ewer; G Viale; S Delaloge; J -M Ferrero; M Verrill; R Colomer; C Vieira; T L Werner; H Douthwaite; D Bradley; M Waldron-Lynch; A Kiermaier; J Eng-Wong; C Dang
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.